Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients
Open Access
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 35, S35-S49
- https://doi.org/10.1016/s0920-9964(98)00162-5
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor MechanismScience, 1997
- The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserinJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- The Effects of Clozapine on Symptom Clusters in Treatment-Refractory PatientsJournal of Clinical Psychopharmacology, 1997
- What can we achieve by implementing a compliance-improvement program?International Clinical Psychopharmacology, 1997
- Motivation to Quit Using Substances Among Individuals With Schizophrenia: Implications for a Motivation-based Treatment ModelSchizophrenia Bulletin, 1997
- Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literatureSchizophrenia Research, 1996
- Opposite Modulation of Cocaine-Seeking Behavior by D 1 - and D 2 -Like Dopamine Receptor AgonistsScience, 1996
- Parkinsonism in alcohol withdrawal: case report and review of the literatureClinical Neurology and Neurosurgery, 1995
- Alcohol withdrawal and moodActa Psychiatrica Scandinavica, 1989
- Neurogenetic Adaptive Mechanisms in AlcoholismScience, 1987